Article
Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Disease models & mechanisms - 1 Jan 2014
Valvezan Alexander J, Huang Jian, Lengner Christopher J, Pack Michael, Klein Peter S
Abstract excerpt
Truncating mutations in adenomatous polyposis coli (APC) are strongly linked to colorectal cancers. APC is a negative regulator of the Wnt pathway and constitutive Wnt activation mediated by enhanced Wnt-β-catenin target gene activation is believed to be the predominant mechanism responsible for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
